Found: 14
Select item for more details and to access through your institution.
Challenges in Treatment Development for Lupus: is it the Targets or the Trials?
- Published in:
- International Journal of Advances in Rheumatology, 2010, v. 8, n. 4, p. 137
- By:
- Publication type:
- Article
Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 3, p. 323, doi. 10.1007/s13365-018-0615-7
- By:
- Publication type:
- Article
320. Pediatric open-label clinical study of rituximab for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
- Published in:
- Rheumatology, 2018, v. 57, n. 4, p. 639, doi. 10.1093/rheumatology/kex484
- By:
- Publication type:
- Article
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 736, doi. 10.1002/art.42388
- By:
- Publication type:
- Article
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 1, p. 124, doi. 10.1002/art.41901
- By:
- Publication type:
- Article
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1888, doi. 10.1002/art.41017
- By:
- Publication type:
- Article
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 7, p. 1114, doi. 10.1002/art.40471
- By:
- Publication type:
- Article
The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 1, p. 169, doi. 10.1002/art.39822
- By:
- Publication type:
- Article
A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 101, p. 1, doi. 10.1126/scitranslmed.3002432
- By:
- Publication type:
- Article
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
- Published in:
- Journal of Nephrology (JNonline), 2015, v. 28, n. 1, p. 17, doi. 10.1007/s40620-014-0135-3
- By:
- Publication type:
- Article
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Arthritis Care & Research, 2017, v. 69, n. 7, p. 1004, doi. 10.1002/acr.23099
- By:
- Publication type:
- Article
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article